Endocrine Society Continues Work on Personal Care Products Safety

The Society is working with the Senate on bipartisan legislation introduced by Senators Dianne Feinstein (D-CA) and Susan Collins (R-MA) known as the Personal Care Products Safety Act (S. 1014). If passed, this bill would amend the Federal Food, Drug, and Cosmetic Act to allow the FDA to collect information on the ingredients of personal care products and prohibit distribution of a personal care product if an ingredient could cause serious adverse health consequences. It would also require the FDA to review the safety of at least five cosmetic ingredients each year.

On August 30-31, the Society participated in a Hill Day with other supporters of the bill, including several cosmetic companies. We met with staff from the offices of Senators Michael Bennet (D-CO), Chuck Schumer (D-NY), Lamar Alexander (R-TN), Sheldon Whitehouse (D-RI), and Patty Murray (D-WA). During the meetings, we learned that the bill faces an uncertain future, as the short work period before the election will prevent action on many pending bills in the Congress.

Take Action: It is important that all Senators hear from their constituents. Please join our online campaign to urge Senators to support S. 1014 so that the Congress will prioritize reform of personal care products. Joining our campaign is quick and easy. Click to access the campaign, and a pre-written letter will be provided for you. You will only need to either provide your email and member ID, OR enter your address information so that the system will send your message to the correct recipients.

You may also like

  • Endocrine Society Advocacy Update – March 2024

    Endocrine Society Advocates to Protect and Increase Funding for the NIH  On March 5, the Endocrine Society will conduct a Researcher Hill Day to advocate for the importance of the National Institutes of Health (NIH). We are asking Congress to complete work on a funding bill for the remainder of fiscal year (FY) 2024, before…

  • Advocacy Update: February 2024

    Federal Funding for SDP, NIH in Jeopardy As the February issue of Endocrine News went to press, the government had only days to fund the Special Diabetes Program (SDP) and the National Institutes of Health (NIH) before funding expired.  It was expected that Congress would pass another short-term funding bill that would fund these programs…